[{"NetIncomeLoss_1_Q2_USD":-7636000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":4465000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":2660000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":36459244.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":55081397.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":1820000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-12000.0,"AccountsPayableRelatedPartiesCurrent_0_Q2_USD":20000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":1457000.0,"MarketableSecuritiesCurrent_0_Q2_USD":31998000.0,"Depreciation_2_Q2_USD":16000.0,"PaymentsToAcquireInvestments_2_Q2_USD":32037000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":13000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":778000.0,"AssetsCurrent_0_Q2_USD":404875000.0,"DepositsAssetsCurrent_0_Q2_USD":104000.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":2687000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":755000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions_0_Q2_Security":8.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":254271000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":33710000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-14000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_2_Q2_USD":-5000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":5027000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":4696000.0,"TemporaryEquityLiquidationPreference_0_Q2_USD":0.0,"TemporaryEquitySharesAuthorized_0_Q2_shares":0.0,"PrepaidExpenseCurrent_0_Q2_USD":1859000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":217000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":51000.0,"CommonStockValue_0_Q2_USD":6000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_2_Q2_USD":170068000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-168000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":1075000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":378988000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-13318000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-7650000.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.0001,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":370838000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":426680000.0,"Liabilities_0_Q2_USD":3545000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":5000.0,"DebtInstrumentInterestRateStatedPercentage_0_Q2_pure":0.08,"ResearchAndDevelopmentExpense_2_Q2_USD":8902000.0,"CommonStockSharesIssued_0_Q2_shares":55617322.0,"ShareBasedCompensation_2_Q2_USD":1890000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":32010000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":128000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-25073000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":368459000.0,"CommonStockSharesOutstanding_0_Q2_shares":55114729.0,"InvestmentsFairValueDisclosure_0_Q2_USD":401794000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":21000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":1000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":1890000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":216000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1243000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":733000.0,"LiabilitiesCurrent_0_Q2_USD":3405000.0,"AccountsPayableCurrent_0_Q2_USD":1585000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":370838000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":2039000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":239000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_2_Q2_USD":124712000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":271000.0,"NetIncomeLoss_2_Q2_USD":-13150000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-11986000.0,"Assets_0_Q2_USD":405146000.0,"StockholdersEquity_0_Q2_USD":401601000.0,"ProfitLoss_2_Q2_USD":-13150000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"InterestReceivableCurrent_0_Q2_USD":76000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":801000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":1624000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"OperatingIncomeLoss_2_Q2_USD":-13367000.0,"OperatingIncomeLoss_1_Q2_USD":-7687000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":31998000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":254271000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":140000.0,"OperatingLeaseCost_2_Q2_USD":212000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":405146000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":941000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":1890000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":1243000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":292000.0,"OperatingExpenses_2_Q2_USD":13367000.0,"OperatingExpenses_1_Q2_USD":7687000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.36,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.14,"OperatingLeaseCost_1_Q2_USD":136000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":242000.0,"Ticker":"DSGN","CIK":"1807120","name":"DESIGN THERAPEUTICS, INC.","OfficialName":"Design Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"802639248.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210809"}]